|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase IV
|
|
|
|
Prevention
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
Pharmaceutical / Industry
|
|
|
|
0468H1-407 NCT00129961
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III, Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 to 70
|
|
|
|
Other
|
|
|
|
#4279 NCT00328770
|
|
|
|
|
|
|
|
Last Modified: 10/21/2008  First Published: 7/23/2004 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care
|
|
|
|
Closed
|
|
|
|
4 and over
|
|
|
|
NCI
|
|
|
|
FHCRC-1697.00 5332, ROCHE-FHCRC-1697.00, NCT00089141, UMN-2004UC007
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II, Phase I
|
|
|
|
Supportive care
|
|
|
|
Closed
|
|
|
|
13 and over
|
|
|
|
NCI
|
|
|
|
FHCRC-1096.00 NCI-H96-0928, NCT00002790
|
|
|
|
|
|
|
|
Last Modified: 3/11/2008  First Published: 10/1/2002 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II, Phase I
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
UCLA-0203078 NCI-G02-2114, NCT00047073
|
|
|
|
|
|
|
|
Last Modified: 4/21/2005  First Published: 7/23/2004 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II, Phase I
|
|
|
|
Supportive care
|
|
|
|
Closed
|
|
|
|
Per primary treatment protocol
|
|
|
|
NCI
|
|
|
|
FHCRC-1811.00 NCT00089037
|
|
|
|
|
|
|
|
Last Modified: 11/1/2006  First Published: 2/20/2004 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Supportive care
|
|
|
|
Closed
|
|
|
|
Any age
|
|
|
|
NCI
|
|
|
|
FHCRC-1706.00 NCT00079183
|
|
|
|
|
|
|
|
Last Modified: 10/7/2008  First Published: 7/23/2005 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 to 65
|
|
|
|
NCI
|
|
|
|
DFCI-04298 WYETH-C-0468H1-101899, NCT00126672
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Supportive care, Treatment
|
|
|
|
Closed
|
|
|
|
18 to 65
|
|
|
|
Other
|
|
|
|
05-154 NCT00133367
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase II
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
60 and over
|
|
|
|
Other
|
|
|
|
0402008 GOELAMS, PHRC, NCT00235560
|
|
|
|